{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:43:08Z","timestamp":1778031788275,"version":"3.51.4"},"reference-count":59,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Teva Pharma Spain","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.1080\/14737167.2020.1768850","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T15:34:50Z","timestamp":1591112090000},"page":"285-297","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain"],"prefix":"10.1080","volume":"21","author":[{"given":"Pablo","family":"Irimia","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurosurgery, Navarra University Clinic, Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Santos-Lasaosa","sequence":"additional","affiliation":[{"name":"Neurology Department, Lozano Blesa University Clinical Hospital, Zaragoza, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Arag\u00f3n (IISA), Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Garc\u00eda Bujalance","sequence":"additional","affiliation":[{"name":"Teva Pharma Spain, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ramos Pinazo","sequence":"additional","affiliation":[{"name":"Teva Pharma Spain, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar\u00edo","family":"Rubio-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Health Value, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rubio-Terr\u00e9s","sequence":"additional","affiliation":[{"name":"Health Value, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6,2]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30322-3"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410382794"},{"key":"cit0004","volume-title":"Grupo de Trabajo Multidisciplinar del Atlas de Migra\u00f1a en Espa\u00f1a. Impacto y situaci\u00f3n de la migra\u00f1a en Espa\u00f1a: atlas 2018","author":"Garrido M","year":"2018"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(03)00293-8"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-012-0460-7"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30478-1"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1111\/head.12055"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2012.00530.x"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414547138"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32504-8"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/head.13302"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0955-y"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1016\/S1086-5802(16)31229-3"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/58.12.1126"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2004.10.3.259"},{"issue":"2","key":"cit0018","first-page":"S62","volume":"11","author":"Goldberg LD","year":"2005","journal-title":"Am J Manag Care"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S121093"},{"key":"cit0020","first-page":"794","volume":"14","author":"Anguita P","year":"2019","journal-title":"Rev Esp Econ Salud"},{"key":"cit0021","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation","author":"Briggs A","year":"2006"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12393"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00824-3"},{"key":"cit0024","unstructured":"A long-term efficacy, safety, and tolerability study of BOTOX\u00ae in patients with chronic migraine. [cited 2020 Jan 29]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01516892?term=COMPEL+study&draw=2&rank=1"},{"key":"cit0025","unstructured":"Comparing efficacy and safety of 2 dose regimens of subcutaneous Administration of TEV-48125 versus placebo for the preventive treatment of chronic migraine. [cited 2019 Mar 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02621931?term=fremanezumab&rank=7"},{"key":"cit0026","unstructured":"Efficacy and safety of 2 dose regimens of TEV-48125 versus placebo for the preventive treatment of episodic migraine. [cited 2019 Mar 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02629861?term=fremanezumab&rank=6"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709038"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4853"},{"key":"cit0029","unstructured":"An efficacy and safety study of fremanezumab in adults with migraine (FOCUS). [cited 2019 Mar 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03308968"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31946-4"},{"key":"cit0031","unstructured":"Study to evaluate the efficacy and safety of erenumab (AMG 334) in migraine prevention (STRIVE). [cited 2019 Mar 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02456740?term=erenumab&draw=2&rank=14"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"cit0033","unstructured":"Study to evaluate the efficacy and safety of erenumab (AMG 334) compared to placebo in migraine prevention (ARISE). [cited 2019 Mar 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02483585?term=erenumab&rank=10"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418759786"},{"key":"cit0035","unstructured":"Evaluation of galcanezumab in the prevention of episodic migraine- the EVOLVE-1 study (EVOLVE-1). [cited 2019 Apr 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02614183?term=Galcanezumab&draw=2&rank=11"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212"},{"key":"cit0037","unstructured":"Evaluation of efficacy & safety of galcanezumab in the prevention of episodic migraine- the EVOLVE-2 study (EVOLVE-2). [cited 2019 Apr 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02614196?term=evolve+2&rank=1"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418779543"},{"key":"cit0039","unstructured":"Evaluation of galcanezumab in the prevention of chronic migraine (REGAIN). [cited 2019 Apr 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02614261?term=GALCANEZUMAB+REGAIN&rank=1"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006640"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002801"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32534-0"},{"key":"cit0044","unstructured":"Orden 727\/2017, de 7 de agosto, del Consejero de Sanidad, por la que se fijan los precios p\u00fablicos por la prestaci\u00f3n de los servicios y actividades de naturaleza sanitaria de la red de centros de la Comunidad de Madrid. [Order 727\/2017, dated 7 August, of the Regional Minister of Health, setting the public prices for the provision of health services and activities of the network of centres in the Community of Madrid]. Official Gazette of the Community of Madrid No. 198; 2017 Aug 21."},{"key":"cit0045","volume-title":"Tarifas para facturaci\u00f3n de servicios sanitarios y docentes del Servicio vasco de salud para el a\u00f1o 2019. [Rates for billing of health and teaching services of the Basque Health Service for 2019]","year":"2019"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.4321\/S1135-57272013000100004"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.recot.2012.06.002"},{"key":"cit0048","first-page":"325","volume":"16","author":"Beteg\u00f3n L","year":"2014","journal-title":"Eur J Clin Pharm"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1007\/s40277-014-0029-8"},{"key":"cit0050","volume-title":"Estudio de evaluaci\u00f3n econ\u00f3mica de la accidentabilidad de las personas mayores en Espa\u00f1a","author":"Mapfre","year":"2012"},{"key":"cit0051","first-page":"240","volume":"37","author":"Oyag\u00fcez I","year":"2013","journal-title":"Farm Hosp"},{"key":"cit0052","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rpsm.2015.08.002","volume":"9","author":"Rejas Guti\u00e9rrez J","year":"2016","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.36469\/9823"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2009.05.017"},{"key":"cit0055","unstructured":"A study to evaluate the efficacy and safety of erenumab (AMG 334) in chronic migraine prevention (2018). [cited 2019 Dec 3]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02066415?term=erenumab+chronic&draw=2&rank=1"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01097-3"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S132833"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008743"},{"key":"cit0059","unstructured":"National Cancer Institute. Instructions and guidelines. Version 3.0, Release 4; 2008 Jan 15 cited 2020 Apr 28. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/cdus_ig_3r4.pdf"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2020.1768850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T20:48:57Z","timestamp":1722977337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2020.1768850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,4]]}},"alternative-id":["10.1080\/14737167.2020.1768850"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2020.1768850","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}